articleNatureFeb 3, 2010BRONZE OA

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

GHGeorgia HatzivassiliouKSKyung SongIYIvana YenBJBarbara J. BrandhuberDJDaniel J. Anderson

Array BioPharma (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,626
total citations
FWCI
70.23
Percentile
100%
References
33
Citations per year

Authors

21

Topics & keywords

Topics
Keywords
  • KRAS
  • MAPK/ERK pathway
  • Cancer research
  • Context (archaeology)
  • Kinase
  • Melanoma
  • Trametinib
  • Vemurafenib
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding